AMPK synergizes with the combined treatment of 1′-acetoxychavicol acetate and sodium butyrate to upregulate phase II detoxifying enzyme activities

Molecular Nutrition and Food Research

Volumn 57, Issue 7, 2013, Pages 1198-1208

  Yaku, Keisuke ^a   Matsui Yuasa, Isao ^a,b   Konishi, Yotaro ^a   Kojima Yuasa, Akiko ^a  

^a Osaka Prefecture University   (Japan)

^b WAKAYAMA UNIVERSITY   (Japan)

Author keywords

1' Acetoxychavicol acetate; AMP activated protein kinase; Dietary fiber; Phase II enzyme; Rat intestine epithelial cells

Indexed keywords

1' ACETOXYCHAVICOL ACETATE; 1'-ACETOXYCHAVICOL ACETATE; BENZYL ALCOHOL DERIVATIVE; BUTYRIC ACID; CATECHIN; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; GLUTATHIONE TRANSFERASE P1; GSTP1 PROTEIN, RAT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; NFE2L2 PROTEIN, RAT; NQO1 PROTEIN, RAT; PROTEIN P53; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TRANSCRIPTION FACTOR NRF2; XENOBIOTIC AGENT;

AMP-ACTIVATED PROTEIN KINASE; ANIMAL; ARTICLE; CELL CULTURE; DIETARY FIBER; DRUG DETOXIFICATION; DRUG EFFECT; DRUG POTENTIATION; EPITHELIUM CELL; GENETICS; METABOLISM; PHASE II ENZYME; PHOSPHORYLATION; RAT; RAT INTESTINE EPITHELIAL CELLS; UPREGULATION;

1'-ACETOXYCHAVICOL ACETATE; AMP-ACTIVATED PROTEIN KINASE; DIETARY FIBER; PHASE II ENZYME; RAT INTESTINE EPITHELIAL CELLS;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BENZYL ALCOHOLS; BUTYRIC ACID; CATECHIN; CELLS, CULTURED; DRUG SYNERGISM; EPITHELIAL CELLS; GLUTATHIONE S-TRANSFERASE PI; METABOLIC DETOXICATION, PHASE II; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; PHOSPHORYLATION; RATS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; XENOBIOTICS;

RATTUS;

EID: 84879799529     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200809     Document Type: Article

References (52)

1. Potter, J. D., Colon cancer-do the nutritional epidemiology, the gut physiology and the molecular biology tell the same story? J. Nutr. 1993, 123, 418-423.
2. Coles, B., Ketterer, B., The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit. Rev. Biochem. Mol. Biol. 1990, 25, 47-70.
3. Joseph, P., Jaiswal, A. K., NAD(P)H: quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. Proc. Natl. Acad. Sci. USA 1994, 91, 8413-8417.
4. Scharlau, D., Borowicki, A., Habermann, N., Hofmann, T. etal., Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre. Mutat. Res. 2009, 682, 39-53.
5. Yaku, K., Enami, Y., Kurajyo, C., Matsui-Yuasa, I. etal., The enhancement of phase 2 enzyme activities by sodium butyrate in normal intestinal epithelial cells is associated with Nrf2 and p53. Mol. Cell Biochem. 2012, 370, 7-14.
6. Murakami, A., Ohara, S., Nakamura, Y., Koshimizu, K. etal., 1′-Acetoxychavicol acetate, a superoxide anion generation inhibitor, potently inhibits tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in ICR mouse skin. Oncology 1996, 53, 386-391.
7. Ohnishi, M., Tanaka, T., Makita, H., Kawamori, T. etal., Chemopreventive effect of a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate, on rat oral carcinogenesis. Jpn. J. Cancer. Res. 1996, 87, 349-356.
8. Tanaka, T., Kawabata, K., Kakumoto, M., Makita, H. etal., Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate. Jpn. J. Cancer Res. 1997, 88, 821-830.
9. Kawabata, K., Tanaka, T., Yamamoto, T., Ushida, J. etal., Suppression of N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis by dietary feeding of 1'-acetoxychavicol acetate. Jpn. J. Cancer. Res. 2000, 91, 148-155.
10. Miyauchi, M., Nishikawa, A., Furukawa, F., Nakamura, H. etal., Inhibitory effects of 1'-acetoxychavicol acetate on N-Nitrosobis(2-oxopropyl)-amine-induced initiation of cholangiocarcinogenesis in Syrian hamsters. Jpn. J. Cancer Res. 2000, 91, 477-481.
11. Moffatt, J., Hashimoto, M., Kojima, A., Kennedy, D.O. etal., Apoptosis induced by 1'-acetoxychavicol acetate in Ehrlich ascites tumor cells is associated with modulation of polyamine metabolism and caspase-3 activation. Carcinogenesis 2000, 21, 2151-2157.
12. Ohnishi, H., Asamoto, M., Tujimura, K., Hokaiwado, N. etal., Inhibition of cell proliferation by nobiletin, a dietary phytochemical, associated with apoptosis and characteristic gene expression, but lack of effect on early rat hepatocarcinogenesis in vivo. Cancer Sci. 2004, 95, 936-942.
13. Zheng, Q., Hirose, Y., Yoshimi, N., Murakami, A. etal., Further investigation of the modifying effect of various chemopreventive agents on apoptosis and cell proliferation in human colon cancer cells. J. Cancer. Res. Clin. Oncol. 2002, 128, 539-546.
14. Ito, K., Nakazato, T., Murakami, A., Yamato, K. etal., Induction of apoptosis in human myeloid leukemic cells by 1'-acetoxychavicol acetate through a mitochondrial- and Fas-mediated dual mechanism. Clin. Cancer. Res. 2004, 10, 2120-2130.
15. Higashida, M., Xu, S., Kojima-Yuasa, A., Kennedy, D.O. etal., 1'-Acetoxychavicol acetate-induced cytotoxicity is accompanied by a rapid and drastic modulation of glutathione metabolism. Amino Acids 2009, 36, 107-113.
16. Yaku, K., Matsui-Yuasa, I., Azuma, H., Kojima-Yuasa, A., 1'-Acetoxychavicol acetate enhances the phase II enzyme activities via the increase in intranuclear Nrf2 level and cytosolic p21 level. Am. J. Chin. Med. 2011, 39, 789-802.
17. Gao, S. S., Choi, B. M., Chen, X. Y., Zhu, R. Z. etal., Kaempferol suppresses cisplatin-induced apoptosis via inductions of heme oxygenase-1 and glutamate-cysteine ligase catalytic subunit in HEI-OC1 cell. Pharm. Res. 2010, 27, 235-245.
18. Tanigawa, S., Fujii, M., Hou, D. X., Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin. Free Radic. Biol. Med. 2007, 42, 1690-1703.
19. Sahin, K., Tuzcu, M., Gencoglu, H., Dogukan, A. etal., Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci. 2010, 87, 240-245.
20. Liu, R. H., Potential synergy of phytochemicals in cancer prevention: mechanism of action. J. Nutr. 2004, 134, 3479-3485.
21. Ricciardiello, L., Bazzoli, F., Fogliano, V., Phytochemicals and colorectal cancer prevention: myth or reality? Nat. Rev. Gastroenterol. Hepatol. 2011, 8, 592-596.
22. Hardie, D. G., Carling, D., The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur. J. Biochem. 1997, 246, 259-273.
23. Hardie, D. G., Carling, D., Gamblin, S. J., AMP-activated protein kinase: also regulated by ADP? Trends Biochem. Sci. 2011, 36, 470-477.
24. Xiao, B., Sanders, M. J., Underwood, E., Heath, R. etal., Structure of mammalian AMPK and its regulation by ADP. Nature 2011, 472, 230-233.
25. Liu, X. M., Peyton, K. J., Shebib, A. R., Wang, H. etal., Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival. Am. J. Physiol. Heart Circ. Physiol. 2011, 300, H84-H93.
26. Lee, S. J., Ando, T., Optically active 1'-acetoxychavicol acetate and its positional isomers: synthesis and repellent effect against adzuki bean weevil. J. Pestic. Sci. 2001, 26, 76-81.
27. Habig, W. H., Pabst, M. J., Jakoby, W. B., Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249, 7130-7139.
28. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
29. Prochaska, H. J., Santamaria, A. B., Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. Anal. Biochem. 1988, 169, 328-336.
30. Itoh, K., Chiba, T., Takahashi, S., Ishii, T. et al., Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 1997, 236, 313-322.
31. Fraonio, R., Vergara, P., Di M. D., Pierantoni, M. G. et al., p53 suppresses the Nrf2-dependent transcription of antioxidant response genes. J. Biol. Chem. 2006, 281, 39776-39784.
32. Singh, S., Okamura, T., Ali-Osman, F., Serine phosphorylation of glutathione S-transferase P1 (GSTP1) by PKCα enhances GSTP1-dependent cisplatin metabolism and resistance in human glioma cells. Biochem. Pharmacol. 2010, 80, 1343-1355.
33. Filomeni, G., Desidenri, E., Cardaci, S., Graziani, I. et al., Carcinoma cells activate AMP-activated protein kinase-dependent autophagy as survival response to kaempferol-mediated energetic impairment. Autophagy 2010, 6, 202-216.
34. Ahn, J., Lee, H., Kim, S., Park, J. et al., The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem. Biophys. Res. Commun. 2008, 373, 545-549.
35. Hwang, T. J., Park, J. I., Shin, I. J., Lee, K. Y. et al., Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem. Biophys. Res. Commun. 2005, 338, 694-699.
36. Collins, Q. F., Liu, H. Y., Pi, J., Liu, Z. et al., Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5'-AMP-activated protein kinase. J. Biol. Chem. 2007, 282, 30143-30149.
37. Murase, T., Misawa, K., Haramizu, S., Hase, T., Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway. Biochem. Pharmacol. 2009, 78, 78-84.
38. Velmurugan, K., Alam, J., McCord, J. M., Pugazhenthi, S., Synergistic induction of heme oxygenase-1 by the components of the antioxidant supplement Protandim. Free Radic. Biol. Med. 2009, 46, 430-440.
39. Saw, C. L., Cintron, M., Wu, T. Y., Guo, Y. et al., Pharmacodynamics of dietary phytochemical indoles I3C and DIM: induction of Nrf2-mediated phase II drug metabolizing and antioxidant genes and synergism with isothiocyanates. Biopharm. Drug Dispos. 2011, 32, 289-300.
40. Lo, H. W., Antoun, G. R., Ali-Osman, F., The human glutathione S-transferase P1 protein is phosphorylated and its metabolic function enhanced by the Ser/Thr protein kinases, cAMP-dependent protein kinase and protein kinase C, in glioblastoma cells. Cancer Res. 2004, 64, 9131-9138.
41. Munoz-Fontela, C., Gonzalez, D., Marcos-Villar, L., Campagna, M. et al., Acetylation is indispensable for p53 antiviral activity. Cell Cycle 2011, 10, 3701-3705.
42. Prives, C., Manley, J. L., Why is p53 acetylated? Cell 2001, 107, 815-818.
43. Gu, W., Roeder, R. G., Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 1997, 90, 595-606.
44. Zhao, Y., Lu, S., Wu, L., Chai, G. et al., Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1). Mol. Cell Boiol. 2006, 26, 2782-2790.
45. Sealy, L., Chalkley, R., The effect of sodium butyrate on histone modification. Cell 1978, 14, 115-121.
46. Hardie, D. G., AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev. 1978, 25, 1895-1908 .
47. Hardie, D. G., Sensing of energy and nutrients by AMP-activated protein kinase. Am. J. Clin. Nutr. 2011, 93, 891S-896S.
48. Ponticos, M., Lu, Q. L., Morgan, J. E., Hardie, D. G. et al., Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle. EMBO J. 1998, 17, 1688-1699.
49. Dasgupta, B., Milbrandt, J., Resveratrol stimulates AMP kinase activity in neurons. Proc. Natl. Acad. Sci. USA, 2007, 104, 7217-7222.
50. Hsu, M. H., Savas, U., Lasker, J. M., Johnson, E. F., Genistein, resveratrol, and 5-aminoimidazole-4-carboxamide-1-b-D-ribofuranoside induce cytochrome P450 4F2 expression through an AMP-activated protein kinase-dependent pathway. J. Pharmacol. Exp. Ther. 2011, 337, 125-136.
51. Pearson, K. J., Lewis, K. N., Price, N. L., Chang, J. W. et al., Nrf2 mediates cancer protection but not prolongevity induced by caloric restriction. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 2325-2330.
52. Kwon, J., Han, E., Bui, C.B., Shin, W. et al., Assurance of mitochondrial integrity and mammalian longevity by the p62-Keap1-Nrf2-Nqo1 cascade. EMBO Rep. 2012, 13, 150-156.